National Pension Service’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81.5M Buy
2,406,013
+112,357
+5% +$3.74M 0.05% 261
2026
Q1
$69.1M Sell
2,293,656
-1,206,902
-34% -$38.8M 0.05% 267
2025
Q4
$109M Buy
3,500,558
+1,427,265
+69% +$35.2M 0.08% 198
2025
Q3
$41.9M Buy
2,073,293
+404,526
+24% +$7.11M 0.03% 349
2025
Q2
$28M Buy
1,668,767
+13,375
+0.8% +$216K 0.02% 406
2025
Q1
$25.4M Sell
1,655,392
-1,429,497
-46% -$25.5M 0.02% 408
2024
Q4
$68M Sell
3,084,889
-85,751
-3% -$1.56M 0.06% 227
2024
Q3
$57.1M Buy
3,170,640
+1,640,940
+107% +$28.7M 0.06% 283
2024
Q2
$24.9M Sell
1,529,700
-92,678
-6% -$1.43M 0.03% 473
2024
Q1
$22.9M Buy
1,622,378
+1,611,856
+15,319% +$20.3M 0.03% 473
2023
Q4
$110K Hold
10,522
﹤0.01% 486
2023
Q3
$108K Hold
10,522
﹤0.01% 487
2023
Q2
$79.7K Sell
10,522
-1,258,962
-99% -$10.2M ﹤0.01% 476
2023
Q1
$11.2M Buy
1,269,484
+1,267,316
+58,456% +$12.5M 0.02% 446
2022
Q4
$19.8K Hold
2,168
﹤0.01% 507
2022
Q3
$17K Hold
2,168
﹤0.01% 515
2022
Q2
$16K Buy
2,168
+277
+15% +$2.41K ﹤0.01% 510
2022
Q1
$18K Hold
1,891
﹤0.01% 510
2021
Q4
$15K Hold
1,891
﹤0.01% 504
2021
Q3
$18K Sell
1,891
-779,258
-100% -$7.3M ﹤0.01% 485
2021
Q2
$7.73M Buy
781,149
+93,279
+14% +$987K 0.01% 448
2021
Q1
$7.94M Buy
687,870
+393,988
+134% +$4.52M 0.02% 448
2020
Q4
$2.84M Sell
293,882
-1,423,194
-83% -$13.6M 0.01% 446
2020
Q3
$15.1M Hold
1,717,076
0.04% 431
2020
Q2
$21.2M Buy
+1,717,076
New +$19.4M 0.06% 363
2019
Q4
Sell
-1,166,208
Closed -$8.02M 517
2019
Q3
$8.02M Buy
1,166,208
+46,602
+4% +$357K 0.03% 430
2019
Q2
$10.3M Sell
1,119,606
-170,057
-13% -$2.05M 0.03% 432
2019
Q1
$20.2M Buy
1,289,663
+40,920
+3% +$722K 0.08% 302
2018
Q4
$21.6M Buy
1,248,743
+77,469
+7% +$1.59M 0.09% 268
2018
Q3
$25.2M Buy
1,171,274
+249,346
+27% +$5.79M 0.1% 237
2018
Q2
$22.8M Buy
921,928
+36,706
+4% +$749K 0.1% 251
2018
Q1
$15.1M Sell
885,222
-169,861
-16% -$3.32M 0.08% 364
2017
Q4
$20M Buy
1,055,083
+171,940
+19% +$2.59M 0.1% 257
2017
Q3
$15.2M Buy
883,143
+36,858
+4% +$829K 0.08% 305
2017
Q2
$27.8M Buy
846,285
+114,247
+16% +$3.54M 0.17% 161
2017
Q1
$23.9M Buy
732,038
+57,726
+9% +$1.97M 0.16% 161
2016
Q4
$24.4M Buy
+674,312
New +$26.9M 0.17% 162

Other funds holding TEVA

National Pension Service's TEVA Position: Q2 2026 in Review

National Pension Service increased its Teva Pharmaceuticals (TEVA) stake by 4.9% in Q2 2026, buying an estimated $3.74M and bringing the position to 2,406,013 shares worth $81.5M. The position accounts for 0.05% of the portfolio, ranked #261.

National Pension Service first reported a position in TEVA in Q4 2016 and has held it in 37 quarters since. The position peaked at $109M in Q4 2025. 528 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • National Pension Service held 2,406,013 shares of Teva Pharmaceuticals worth $81.5M as of Q2 2026.
  • National Pension Service bought 112,357 Teva Pharmaceuticals shares in Q2 2026, an estimated $3.74M.
  • Teva Pharmaceuticals made up 0.05% of National Pension Service's portfolio in Q2 2026, its #261 holding.
  • National Pension Service first reported a position in Teva Pharmaceuticals in Q4 2016 and has held it in 37 quarters since.
  • National Pension Service's Teva Pharmaceuticals position peaked at $109M in Q4 2025.
  • 528 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on National Pension Service's 13F filing for Q2 2026, filed 13 Aug 2026.